Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Industry Valuation for the Peptide Antibiotics Sector?

In recent times, the peptide antibiotics market has been recording robust growth. This sector, currently valued at $5.25 billion in 2024, is projected to increase to $5.77 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%. Factors that sparked the growth during the historic period include discoveries and advances in peptide antibiotics, a rise in antibiotic resistance, an increase in infectious diseases, advancements in peptide synthesis technologies, and the expansion of the pharmaceutical industry.

In the ensuing years, the peptide antibiotics market is projected to experience significant expansion, inflating to “$8.29 billion by 2029 with a compound annual growth rate (CAGR) of 9.5%. Various factors such as emphasis on the creation of new antibiotics, a worldwide increase in antibiotic-resistant infections, growth in research and development in antimicrobial peptides, and regulatory backing for new antibiotic approvals could contribute to growth in the forecast period. Key trends for this period include investigating natural sources for antimicrobial peptides, using peptide antibiotics for animal health, focusing on peptide engineering for improved effectiveness, developing combination peptide antibiotics, and incorporating artificial intelligence and machine learning into peptide antibiotic discovery.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp

What Forces Are Driving The Growth Of The Peptide Antibiotics Market?

The augmented presence of various communicable diseases is projected to stimulate the expansion of the peptide antibiotics market. Illnesses resulting from harmful organisms such as bacteria, fungi, parasites, and more constitute infectious diseases. Factors contributing to the increment in infectious diseases include rapid urbanization, climate change, and increased danger of disease manifestation among others, leading to heightened demands for peptide antibiotics. These antibiotics penetrate and break cell membranes, strengthening their antibacterial properties. The World Health Organization, a Swiss intergovernmental organization, noted in May 2024 that dengue cases in the Americas had already exceeded seven million by April 2024, a significant rise compared to the 4.6 million cases recorded throughout 2023. As such, the escalating incidences of infectious diseases propel the growth of the peptide antibiotics market.

How Is The Peptide Antibiotics Industry Segmented Across Key Parameters?

The peptide antibiotics market covered in this report is segmented –

1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics

2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs

3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases

4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels

Subsegments:

1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides

2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic Lipopeptides

What Future Market Trends Are Projected For The Peptide Antibiotics Industry?

Strategic alliances are becoming a prevalent trend in the peptide antibiotics market. The main companies in this market are forming collaborations to broaden their reach and maximize each other’s assets. For example, in January 2022, Berkeley Lights, an American digital cell biology firm, aligned with Aanika Biosciences. Through this alliance, Aanika will employ the high-throughput, functional screening services of Berkeley Lights for the quick identification and refinement of effective antimicrobial peptides (AMPs) that can eradicate harmful bacteria, particularly those causing foodborne illnesses. Moreover, the Beacon Optofluidic Platform will be utilized to identify peptides that possess antibacterial properties, and these will be integrated into a unique antibacterial tag. This tag will subsequently be applied in the bacterial spore-based barcoding technology of Aanika Biosciences to safeguard the food supply chain. Aanika Biosciences is a bio-tech company based in the United States.

Which Companies Currently Dominate The Competitive Landscape In The Peptide Antibiotics Industry?

Major companies operating in the peptide antibiotics market include Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Antabio, Basilea Pharmaceutica Ltd., BioVersys AG

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

Which Geographic Regions Are Driving Demand In The Peptide Antibiotics Market?

North America was the largest region in the peptide antibiotics market in 2024. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7780&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model